Thermo Fisher Scientific INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NYSE
Thermo Fisher Scientific's 2026 proxy statement details 2025 financial performance, executive compensation adjustments, and the approval of a performance-based CEO retention grant.
NYSE
Thermo Fisher Scientific has filed a definitive proxy statement with the SEC.
NYSE
DEF 14A: Thermo Fisher Scientific Faces Shareholder Vote on Executive Pay and Special Meeting Rights
Thermo Fisher Scientific's upcoming annual meeting will address director elections, executive compensation, auditor ratification, and a shareholder proposal regarding special meeting rights.
NYSE
Thermo Fisher Scientific Inc. has filed a definitive proxy statement with the SEC.
NYSE
Thermo Fisher Scientific's proxy statement outlines executive compensation, board governance practices, and proposals for the upcoming annual meeting.